Skip to main content

Closed

KYMR: Kymera Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

71thpctl

Volume

0.63×avg

Market Cap

8.51BUSD

P/E Ratio

-28.9TTM

Div Yield

-ann

Kymera Therapeutics, Inc.

KYMRNASDAQ Global Market·USD·Closed

Kymera Therapeutics, Inc.

KYMRNASDAQ·USD·Closed

$103.40

−3.37%

$103.40

−$3.61 (3.37%)

52W Range

71thpctl

Volume

0.63×avg

Mkt Cap

8.51BUSD

P/E

-28.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings